Patent ID: 11897946
Assignee: DUKE UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C  G

Claim 8:
9. The method of claim 1, wherein the method further comprises administering a therapeutically effective amount of one or more of doxorubicin, epirubicin, daunorubicin, capecitabine, carboplatin, cisplatin, cyclophosphamide, eribulin, fluorouracil, gemcitabine, ixabepilone, methotrexate, mitoxantrone, mitomycin, paclitaxel, docetaxel, thiotepa, vincristine, vinorelbine, lapatinib, onartuzumab, rilotumumab, ficlatuzumab, bevacizumab, rituximab, panatumamab, cetuximab, pertuzumab, or trastuzumab.